News & Media

Latest Press Release

June 1, 2020

ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-viral Candidate for Treatment of COVID-19

Westport, CT, June 01, 2020 (GLOBE NEWSWIRE) -- Company to provide updates on the initiation of human trials for treatment of adult hospitalized patients with COVID-19 Phase II clinical trial will be conducted with merimepodib and remdesivir in multiple sites nationwide with data expected in the third quarter 2020 BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it will host a call to discuss the Phase II…

Read More